PURE Bioscience, Inc. (OTCQB: PURE) is focused on developing and commercializing their proprietary antimicrobial products in the food safety arena. SNNLive caught up with Hank Lambert, CEO of PURE Bioscience, Inc. at the Growth Capital Expo 2015 in Las Vegas, NV.
Mr. Lambert starts off with overview of PURE, “PURE Bioscience is the developer, and we’re commercializing a unique proprietary anti-microbial technology based on silver dihydrogen citrate, or SDC, which has unique properties in breadth and speed of pathogen kill. We are positioning as a food safety solution addressing key issues.”
He continues, “With the rising outbreak of food bourn illnesses tied back to food products, we are positioning our technology today against a major market for food contact surface disinfection, it’s about $1.5 billion - $2 billion market in cleaner sanitizers and disinfectants used by restaurant chains and food processors today. In the future, we have under development a formulation of SDC that can be used in direct food contact and we are preparing to submit for FDA approval in the very near future.”
When asked about how the company plans to compete in the disinfectant space, Mr. Lambert responds, “we are a new and disruptive technology. We are going up against some very sizeable, entrenched competitors, but we believe we have the competitive differentiators to enable us to make significant traction in the market.” He goes to explain how their technology competes with what’s currently available.
For more information about PURE Bioscience, Inc., go to: www.PureBio.com
Since speaking with Mr. Lambert, the company has made the following announcements:
© 2017 Stock News Now
Supported by Superior Web Solutions